Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Quercetin wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
13 of 16 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
13 of 14 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (1)
Outcomes where both Pine Bark Extract and Quercetin have evidence — compare verdict strength side-by-side.
100-200mg daily
Morning with food, Can be divided into two doses
Pycnogenol (standardized extract)
500-1000mg
With meals containing fat, Split into 2 doses
Quercetin phytosome (improved absorption)
4-8 weeks
6-12 weeks
4-8 weeks
Initial use
2-4 weeks
2-4 weeks
4-8 weeks
Phlebotonics for venous insufficiency
The Cochrane database of systematic reviews (2020) · Meta analysis · n=7690
Pooled data suggest that phlebotonics probably increase adverse events slightly, compared to placebo (RR 1.14, 95% CI 1.02 to 1.27; 37 studies; 5789 participants; moderate-certainty evidence).
Pine bark (Pinus spp.) extract for treating chronic disorders
The Cochrane database of systematic reviews (2020) · Meta analysis · n=1641
In a mixed group of participants with type 1 and type 2 DM we do not know whether pine bark extract decreases HbA1c (MD -0.20 %, 95% CI -1.83 to 1.43; one study; 67 participants; very low-certainty evidence).
Effect of pycnogenol supplementation on blood pressure: A systematic review and meta-analysis of clinical trials
Phytotherapy research : PTR (2020) · Meta analysis · n=922
Pooled analysis suggested that pycnogenol supplementation can reduced systolic blood pressure (SBP) of (-3.22 mmHg; 95% CI [-5.52, -0.92]) and diastolic blood pressure (DBP; -1.91 mmHg; 95% CI [-3.64, -0.18]).
Quercetin as a therapeutic agent for skin problems: a systematic review and meta-analysis on antioxidant effects, oxidative stress, inflammation, wound healing, hyperpigmentation, aging, and skin cancer
Naunyn-Schmiedeberg's archives of pharmacology (2025) · Meta analysis · n=1398
Furthermore, quercetin significantly inhibited tyrosinase activity (Z-score, 1.95), resulting in a significantly reduced melanin content (Z-score, 2.56).
Efficacy and safety of dietary polyphenol supplements for COPD: a systematic review and meta-analysis
Frontiers in immunology (2025) · Meta analysis · n=894
This systematic review confirms that the efficacy of dietary polyphenols is significantly composition-specific.
Safety and efficacy of antioxidant therapy in children and adolescents with attention deficit hyperactivity disorder: A systematic review and network meta-analysis
PloS one (2024) · Meta analysis · n=3650
The rankings of safety and efficacy of the 12 antioxidants vary.
Based on meta-analyses showing modest reductions in systolic (-3.22 mmHg) and diastolic (-1.91 mmHg) blood pressure. Effects are clinically small and studies show heterogeneity.
Meta-analysis of 896 subjects showed modest reductions in systolic (-3.09 mmHg) and diastolic (-2.86 mmHg) BP. Effect size is small and bioavailability varies significantly by form.
AI-estimated from published studies. Interpret as directional guidance.
Quercetin has a higher evidence score (6/10 vs 5.5/10) and wins in 1 of 3 categories.
For reduce inflammation, Pine Bark Extract has a higher relevance score (75 vs 70).
No known interactions between Pine Bark Extract and Quercetin have been documented in our database. However, always consult a healthcare provider before combining supplements.